Table 3 Results of included studies for clinical outcome measures. Incomplete data were not included.
| Outcome measure | Study ID | Dx | Intervention | Wk | WMD (95% CI) | RR (95% CI) | p Value |
|---|---|---|---|---|---|---|---|
| Pain | |||||||
| Pain VAS (100 mm) | Silbernagel 200152 | AT | EE vs CE | 6 | 2.00 (−18.90, 22.90) | 0.85 | |
| 12 | 18.00 (−3.68, 39.68) | 0.10 | |||||
| 26 | 10.00 (−8.81, 28.81) | 0.30 | |||||
| Jonsson 200545 | PT | EE vs CE | 12 | 44.80 (20.09, 69.51) | 0.00004 | ||
| Martinez‐Silvestrini 200546 | LET | EE+St vs CE+St | 6 | 8.00 (−8.02, 24.02) | 0.33 | ||
| EE+St vs St | |||||||
| 6 | −1.00 (−16.46, 14.46) | 0.90 | |||||
| Decrease in pain (Yes/No)* | Stasinopoulos 200453 | PT | EE vs US | 4 | 8.00 (1.21, 52.69) | 0.03 | |
| 8 | 21.00 (1.40, 315.98) | 0.03 | |||||
| 16 | 21.00 (1.40, 315.98) | 0.03 | |||||
| EE vs F | 4 | 4.00 (1.11, 14.35) | 0.03 | ||||
| 8 | 5.00 (1.45, 17.27) | 0.01 | |||||
| 16 | 5.00 (1.45, 17.27) | 0.01 | |||||
| FAOS Pain Score (/100) | Roos 200450 | AT | EE vs EE+Sp | 12 | 1.40 (−19.16, 21.96) | 0.89 | |
| 52 | 4.00 (−15.01, 23.01) | 0.68 | |||||
| EE vs Sp | 12 | 14.00 (−6.56, 37.94) | 0.18 | ||||
| 52 | 4.00 (−14.11, 22.11) | 0.67 | |||||
| Function | |||||||
| FAOS Sport/Rec score (/100) | Roos 200450 | AT | EE vs EE+Sp | 12 | 17.00 (−8.87, 42.87) | 0.20 | |
| 52 | 10.00 (−17.94, 37.94) | 0.48 | |||||
| EE vs Sp | 12 | 20.00 (−8.87, 45.87) | 0.13 | ||||
| 52 | 8.00 (−17.89, 33.89) | 0.54 | |||||
| Plantarflexion (°) | Silbernagel 200152 | AT | EE vs CE | 12 | 2.00 (3.36, 7.36) | 0.46 | |
| Jumping test (cm) | Silbernagel 200152 | AT | EE vs CE | 12 | 0.00 (−4.89, 4.89) | 1.00 | |
| Toe raise Test (n) | Silbernagel 200152 | AT | EE vs CE | 12 | −2.00 (−14.55, 10.55) | 0.75 | |
| VISA scores (/100) | Jonsson 200545 | PT | EE vs CE | 12 | 45.90 (24.54, 67.26) | <0.0001 | |
| Visnes 200555 | PT | EE vs C | 12 | 0.10 (−14.38, 14.58) | 0.99 | ||
| Hamstring moment (Nm) | Cannell 200157 | PT | EE vs CE | 12 | 5.00 (−133.98, 143.98) | 0.94 | |
| Quadriceps moment (Nm) | Cannell 200157 | PT | EE vs CE | 12 | 106.00 (−73.74, 285.74) | 0.25 | |
| DASH (/100) | Martinez‐Silvestrini 200546 | LET | EE vs CE | 6 | 0.00 (−9.76, 9.76) | 1.00 | |
| EE+St vs St | 6 | −3.00 (−12.71, 6.71) | 0.54 | ||||
| Ko scores (/100) | Selvanetti 200363 | LET | EE vs US | 4 | 38.70 (29.75, 47.65) | <0.00001 | |
| 48 | 39.20 (30.32, 48.08) | <0.00001 | |||||
| Grip strength (mmHg) | Martinez‐Silvestrini 200546 | LET | EE vs CE | 6 | −3.00 (−13.10, 7.10) | 0.56 | |
| EE+St vs St | 6 | −4.00 (−12.50, 4.50) | 0.36 | ||||
| Satisfaction/ Return to activity | |||||||
| Neisen‐Vertommen 199259 | AT | EE vs CE | 12 | 4.50 (0.63, 32.38) | 0.14 | ||
| Mafi 200127 | AT | EE vs CE | 12 | 2.25 (1.25, 4.05) | 0.007 | ||
| Silbernagel 200152 | AT | EE vs CE | >26 | 1.56 (0.73, 3.32) | 0.25 | ||
| Cannell 200157 | PT | EE vs CE | 12 | 1.35 (0.81, 2.24) | 0.25 | ||
| Jonsson 200545 | PT | EE vs CE | 12 | 17.27 (1.15, 260.07) | 0.04 | ||
| >26 | 17.27 (1.15, 260.07) | 0.04 | |||||
| Svernlov 200154 | LET | EE vs St | >26 | 1.06 (0.81, 1.39) | 0.68 | ||
| Selvanetti 200363 | LET | EE vs US | >26 | 21.97 (3.17, 152.20) | 0.002 |
AT, Achilles tendinopathy; C, control; CE, concentric exercise; CI, confidence interval; DASH, disabilities of the arm, shoulder and hand; DOS, duration of symptoms; Dx, diagnosis; F, frictions; FAOS, foot and ankle outcome score; EE, eccentric exercise; LET, lateral elbow tendinopathy; p, statistical significance; PT, patellar tendinopathy; RCT, randomised controlled trial; RR, relative risk; S, splint; St, stretching; US, ultrasound; VAS, visual analogue scale; VISA, Victorian Institute of Sport Assessment; WMD, weighted mean difference; Wk, week of data collection.
*Yes, much better /no pain; No, worse/no change/slightly better